Enoxaparin vs Continuous Heparin for Periprocedural Bridging in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

Chandler David Schexnayder; Christine Aguilar; Kathleen Morneau

Enoxaparin vs Continuous Heparin for Periprocedural Bridging in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

Fed Pract. 2019 Jul;36(7):306-315.

Authors

Chandler David Schexnayder¹, Christine Aguilar¹, Kathleen Morneau¹

Affiliation

¹ is a Home-Based Primary Care Clinical Pharmacy Specialist, and is an Inpatient Surgery Clinical Pharmacy Specialist, both at the Michael E. DeBakey VA Medical Center in Houston, Texas. is a Clinical Pharmacy Specialist in the Medical Intensive Care Unit and Antimicrobial Stewardship at the Audie L. Murphy Veterans Hospital in San Antonio, Texas.

PMID: 31384119
PMCID: PMC6654170

Abstract

Bridging with enoxaparin rather than heparin has the potential to reduce the length of hospital stay, incidence of nosocomial infections, and cost of hospitalization.